Alzheimer’s/Dementia

Alzheimer’s Association releases new appropriate use criteria for procedures

The appropriate use criteria (AUC) is available online by Alzheimer's & Dementia: The Journal of the Alzheimer's Association as an article in press, corrected proof.

Read More >>

USC scientists map brain with relation to Alzheimer’s

Curing some of the most vexing diseases first requires navigating the world's most complex structure -- the human brain. So, USC scientists have created the most detailed atlas yet of the brain's memory bank.

Read More >>

Scientists see positive results with senolytic therapies and Alzheimer’s

Scientists at the University of Texas have implicated a type of cellular stress for the first time as a player in Alzheimer's disease.

Read More >>

CDC predicts dementia issues will nearly double by 2060

In 2014, 5 million Americans — or 1.6 percent of the population — felt the burden of the diseases.

Read More >>

Scientists develop ability for computer avatars to detect dementia

This technique developed by a team from Osaka University and Nara Institute of Science and Technology involves learning characteristics of sounds of elderly people who answer easy questions.

Read More >>

Some doctors push notion that Alzheimer’s could be infectious

Dr. Leslie Norins is willing to hand over $1 million of his own money to anyone who can clarify something: Is Alzheimer's disease, the most common form of dementia worldwide, caused by a germ?

Read More >>

Researchers find liver drug has benefits for Alzheimer’s treatment

Research reveals that an existing drug used to treat liver disease could also be employed in Alzheimer's disease therapy. The drug "heals" malfunctioning elements at cellular level.

Read More >>

Researchers find possible $4.6 billion in savings for Medicare at cost of long-term care hospital discharges

Medicare could save about $4.6 billion with no negative effect on patients by disallowing discharges to long-term care hospitals, a new SSRN analysis finds. 

Read More >>

Alzheimer’s, down syndrome vaccine trial hits important milestones

Start of Phase 2 trial with ACI-24 in patients with mild Alzheimer's disease with first patient enrolled.

Read More >>

ALS, dementia issues may stem from rogue proteins

Inherited forms of both diseases have been traced to gene mutations associated with an abnormal buildup of the RNA-binding protein, TDP-43, in the brain.

Read More >>